Clinical

Popular weight loss drugs like Wegovy may raise risk of complications under anesthesia
Some anesthesiologists in the U.S. and Canada say they’re seeing more patients on weight-loss drugs inhaling food and liquid into their lungs during sedation.
Millions across the world live with low back pain, but addressing major risk factors like smoking, obesity and workplace ergonomics could curb the trend
Low back pain has ranked first among causes of disability for the last three decades. Back pain, however, is not inevitable, even if that sometimes feels like the case.

Take this empathy and call me in the morning: Could your good vibes ease the pain?

A new study used MRI to scan the brains of patients with chronic pain. It turns out a doctor in the room can make a difference.
Is your patient really allergic to penicillin? Oral challenge is safe way to find out: study

Researchers used a clinical decision tool to identify patients at low risk of a penicillin allergy before giving an oral challenge.
Are they road-safe? New clinical tool grades older drivers’ risk of a crash

The Candrive group used data from the larger prospective trial to develop a four-point risk stratification tool.
QUIZ: Have you heard of alpha-gal syndrome?

Alpha-gal syndrome is in the news. How much do you know about this mysterious condition? Find out here!
POP QUIZ: Dyslipidemia in children

In 2022, the Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association published clinical practice guidelines for the management of dyslipidemia in children and adolescents.
Canada, U.S. consensus guidelines for the management of acetaminophen poisoning

New guidelines have evidence-based recommendations for medical, pharmacy and nursing staff to optimize care of patients with acetaminophen poisoning.
Autistic people at higher risk of self harm and psychiatric illness, study says

The new study, conducted by CAMH and the Institute for Clinical Evaluative Sciences, found that autistic females had an 83% increased risk of self-harm than non-autistic females.
SGLT2 inhibitors may reduce recurrent gout flares in type 2 diabetes patients

Sodium–glucose cotransporter-2 inhibitors may also reduce gout-related emergency department visits and hospitalizations, as well as provide cardiovascular benefits.